Pages that link to "Q37278814"
Jump to navigation
Jump to search
The following pages link to Fifty years of advances in bile acid synthesis and metabolism (Q37278814):
Displaying 50 items.
- Modulation of retinoic acid receptor-related orphan receptor alpha and gamma activity by 7-oxygenated sterol ligands (Q24336344) (← links)
- Absorption-Enhancing Effects of Bile Salts (Q26798510) (← links)
- Nuclear Receptors, RXR, and the Big Bang (Q26821789) (← links)
- Bile acid signaling through farnesoid X and TGR5 receptors in hepatobiliary and intestinal diseases (Q26863752) (← links)
- Bile acids, obesity, and the metabolic syndrome (Q27020976) (← links)
- Faecal bile acids are natural ligands of the mouse accessory olfactory system (Q27342766) (← links)
- Fatty liver diseases, bile acids, and FXR (Q28068199) (← links)
- Improved glucose metabolism following bariatric surgery is associated with increased circulating bile acid concentrations and remodeling of the gut microbiome (Q28070321) (← links)
- Spatial distribution of the pathways of cholesterol homeostasis in human retina (Q28483866) (← links)
- Diet1 functions in the FGF15/19 enterohepatic signaling axis to modulate bile acid and lipid levels (Q28593904) (← links)
- Flux analysis of cholesterol biosynthesis in vivo reveals multiple tissue and cell-type specific pathways (Q28647131) (← links)
- CYP7B1: one cytochrome P450, two human genetic diseases, and multiple physiological functions (Q31083216) (← links)
- Discovery of tauroursodeoxycholic acid biotransformation enzymes from the gut microbiome of black bears using metagenomics (Q33594384) (← links)
- Cholesterol in the retina: the best is yet to come. (Q33758267) (← links)
- The Associations between Circulating Bile Acids and the Muscle Volume in Patients with Non-alcoholic Fatty Liver Disease (NAFLD) (Q33760717) (← links)
- Marked variability in hepatic expression of cytochromes CYP7A1 and CYP27A1 as compared to cerebral CYP46A1. Lessons from a dietary study with omega 3 fatty acids in hamsters (Q33835559) (← links)
- STARTing to understand MLN64 function in cholesterol transport (Q33993101) (← links)
- Getting the mOST from OST: Role of organic solute transporter, OSTalpha-OSTbeta, in bile acid and steroid metabolism (Q34024552) (← links)
- TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading (Q34094979) (← links)
- Rate of steroid double-bond reduction catalysed by the human steroid 5β-reductase (AKR1D1) is sensitive to steroid structure: implications for steroid metabolism and bile acid synthesis (Q34179770) (← links)
- Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist (Q34326973) (← links)
- On the role of gallbladder emptying and incretin hormones for nutrient-mediated TSH suppression in patients with type 2 diabetes (Q34363662) (← links)
- Sodium-dependent bile salt transporters of the SLC10A transporter family: more than solute transporters (Q34382931) (← links)
- On the molecular basis of D-bifunctional protein deficiency type III. (Q34545325) (← links)
- Prox1 directly interacts with LSD1 and recruits the LSD1/NuRD complex to epigenetically co-repress CYP7A1 transcription (Q34692881) (← links)
- Potency of individual bile acids to regulate bile acid synthesis and transport genes in primary human hepatocyte cultures (Q34736335) (← links)
- 27-Hydroxycholesterol: the first identified endogenous SERM (Q34762182) (← links)
- Studies in mice, hamsters, and rats demonstrate that repression of hepatic apoA-I expression by taurocholic acid in mice is not mediated by the farnesoid-X-receptor (Q34955918) (← links)
- Impact of physiological levels of chenodeoxycholic acid supplementation on intestinal and hepatic bile acid and cholesterol metabolism in Cyp7a1-deficient mice (Q34980363) (← links)
- The bile acid membrane receptor TGR5: a valuable metabolic target (Q35082232) (← links)
- A liver-enriched long non-coding RNA, lncLSTR, regulates systemic lipid metabolism in mice. (Q35148521) (← links)
- Impaired generation of 12-hydroxylated bile acids links hepatic insulin signaling with dyslipidemia (Q35661144) (← links)
- A Global Map of Lipid-Binding Proteins and Their Ligandability in Cells. (Q35668656) (← links)
- Regulation of bile acid homeostasis by the intestinal Diet1-FGF15/19 axis (Q35836340) (← links)
- Age-Related Changes of Plasma Bile Acid Concentrations in Healthy Adults--Results from the Cross-Sectional KarMeN Study (Q35993511) (← links)
- Intestinal synthesis and secretion of bile salts as an adaptation to developmental biliary atresia in the sea lamprey (Q36094095) (← links)
- Delineation of biochemical, molecular, and physiological changes accompanying bile acid pool size restoration in Cyp7a1(-/-) mice fed low levels of cholic acid (Q36114905) (← links)
- Thyroid hormone reduces PCSK9 and stimulates bile acid synthesis in humans. (Q36196859) (← links)
- Structural characterization of human cholesterol 7α-hydroxylase (Q36197677) (← links)
- Profile of serum bile acids in noncholestatic volunteers: gender-related differences in response to fenofibrate (Q36338007) (← links)
- Origin of an ancient hormone/receptor couple revealed by resurrection of an ancestral estrogen (Q36354712) (← links)
- Lithocholic acid controls adaptive immune responses by inhibition of Th1 activation through the Vitamin D receptor. (Q36368928) (← links)
- Nuclear receptors HNF4α and LRH-1 cooperate in regulating Cyp7a1 in vivo (Q36436111) (← links)
- Evolution of substrate specificity for the bile salt transporter ASBT (SLC10A2). (Q36520337) (← links)
- The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation (Q36832832) (← links)
- Pleiotropic roles of bile acids in metabolism (Q36843966) (← links)
- Critical role of RanBP2-mediated SUMOylation of Small Heterodimer Partner in maintaining bile acid homeostasis (Q37099513) (← links)
- Homozygosity mapping identifies a bile acid biosynthetic defect in an adult with cirrhosis of unknown etiology (Q37166891) (← links)
- Engineered fibroblast growth factor 19 reduces liver injury and resolves sclerosing cholangitis in Mdr2-deficient mice (Q37337378) (← links)
- Lipoproteins, cholesterol homeostasis and cardiac health (Q37544267) (← links)